Gene Manipulation In Human Embryos Provokes Ethical Questions
By Rahel Gebreyes,
HuffPost Live
| 11. 17. 2015
[cites CGS' Marcy Darnovsky]
Untitled Document
A team of Chinese scientists raised eyebrows in April when they modified the genetic code of human embryos to correct the gene defect that causes the hereditary blood disease beta-thalassemia. Now, many researchers and ethicists fear that the technology used to make those manipulations might one day be "exploited for non-therapeutic modifications" such as selecting for intelligence and physical appearance.
While gene editing technology may offer serious health opportunities, it also poses ethical questions, especially if scientists use it for reasons other than preventing illness or diseases, according to Dr. Marcy Darnovsky, executive director of the Center for Genetics and Society.
"Using gene editing on human embryos for reproduction -- that's not really even a medical approach. That's not treating anybody who is sick. That's creating new human beings," Darnovsky told HuffPost Live's Josh Zepps in a video segment (above) on Monday.
As she explained, gene-modification skeptics have raised a number of objections to the budding technology. Darnovsky said:
"There are totally secular objections to it -- having to do with the safety, having to do with the fact...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...